Utreloxastat

Item number	Size	Delivery time	Price
TGM-T60507-1mg	1 mg	7 - 10 business days*	93.00€
TGM-T60507-5mg	5 mg	7 - 10 business days*	228.00€
TGM-T60507-1mL	1 ml	7 - 10 business days*	247.00€
TGM-T60507-10mg	10 mg	7 - 10 business days*	327.00€
TGM-T60507-25mg	25 mg	7 - 10 business days*	560.00€
TGM-T60507-50mg	50 mg	7 - 10 business days*	828.00€
TGM-T60507-100mg	100 mg	7 - 10 business days*	1,449.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study... more

Close menu

Product information "Utreloxastat"

Description: Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis . Target: Lipoxygenase. Smiles: CCCCCCCCCC1=C(C)C(=O)C(C)=C(C)C1=O. References: Gao L, Giannousis P, et al. First-in-Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15-Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis. Clin Pharmacol Drug Dev. 2023 Feb,12(2):141-151.

Keywords:	EPI 857, PTC857
Supplier:	TargetMol
Supplier-Nr:	T60507

Properties

Application:	Targets arachidonate 15-lipoxygenase [EC:1.13.11.33] (ALOX15)
MW:	276.41 D
Formula:	C18H28O2
Format:	32160405

Database Information

CAS :	1213269-96-5\| Matching products
KEGG ID :	K00460 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Utreloxastat"

Write a review